| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0955-2235(91)90006-P |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:095522359190006P?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:095522359190006P?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 1811790 |
| P2093 | author name string | W. Casscells | |
| P2860 | cites work | Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains | Q24292935 |
| Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors | Q24302929 | ||
| Diverse forms of a receptor for acidic and basic fibroblast growth factors | Q24306588 | ||
| Fibroblast Growth Factor Receptors from Liver Vary in Three Structural Domains | Q24311635 | ||
| A Heparin-Binding Growth Factor Secreted by Macrophage-Like Cells That Is Related to EGF | Q24319855 | ||
| Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation | Q24337851 | ||
| FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern | Q24561476 | ||
| Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3 | Q24564164 | ||
| Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons | Q24610347 | ||
| Platelet-derived growth factor and angiotensin II cause increases in cytosolic free calcium by different mechanisms in vascular smooth muscle cells | Q69588959 | ||
| Control of cell division in hepatoma cells by exogenous heparan sulfate proteoglycan | Q69600182 | ||
| Heparin increases mRNA levels of thrombospondin but not fibronectin in human vascular smooth muscle cells | Q69691512 | ||
| Effects of smooth muscle cell derived growth factor (SDGF) in combination with other growth factors on smooth muscle cells | Q69742285 | ||
| Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells | Q69747770 | ||
| Heparin inhibits inositol trisphosphate-induced calcium release from permeabilized rat liver cells | Q69815830 | ||
| Comparative endocrinology-paracrinology-autocrinology of human adult large vessel endothelial and smooth muscle cells | Q69826088 | ||
| Purification of basic FGF receptors from rat brain | Q69837985 | ||
| Lipoproteins increase growth of mitogen-stimulated arterial smooth muscle cells | Q69964854 | ||
| Cell cycle-dependent inhibition of human vascular smooth muscle cell proliferation by prostaglandin E1 | Q70100779 | ||
| Adenosine receptor-mediated changes in cyclic AMP production and DNA synthesis in cultured arterial smooth muscle cells | Q70101540 | ||
| The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation | Q70126205 | ||
| Stimulation of human arterial smooth muscle cell chondroitin sulfate proteoglycan synthesis by transforming growth factor-beta | Q70136353 | ||
| Modulation of extracellular matrix gene expression by heparin and endothelial cell growth factor in human smooth muscle cells | Q70139586 | ||
| Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents | Q70141795 | ||
| Induction by fibroblast growth factor of angiotensin converting enzyme in vascular endothelial cells in vitro | Q70185812 | ||
| Cell cycle-dependent inhibition of DNA synthesis by prostaglandin I2 in cultured rabbit aortic smooth muscle cells | Q70195010 | ||
| What controls smooth muscle phenotype? | Q71081589 | ||
| Phenotype modulation in primary cultures of arterial smooth muscle cells. On the role of platelet-derived growth factor | Q71241003 | ||
| Demonstration of stimulatory effects of platelet-derived growth factor on cultivated rat arterial smooth muscle cells. Differences between cells from young and adult animals | Q71763226 | ||
| Growth-stimulating effect of catecholamines on rat aortic smooth muscle cells in culture | Q71767137 | ||
| Fibronectin | Q72154087 | ||
| Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells | Q72684288 | ||
| Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury | Q93514193 | ||
| Effect of heparin on vascular smooth muscle cells. I. Cell metabolism | Q93616552 | ||
| Regulation of vascular smooth muscle cell growth by endothelial-synthesized extracellular matrices | Q69439407 | ||
| Differential stimulation of growth related metabolism in cultured smooth muscle cells from SHR and WKY rats by combinations of EGF and LDL | Q69492085 | ||
| Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells | Q69492102 | ||
| Endothelin is a potent mitogen for rat vascular smooth muscle cells | Q69539814 | ||
| Growth factors in early embryogenesis | Q38737593 | ||
| A role for neuropeptides in the control of cell proliferation | Q39153351 | ||
| Transforming growth factor-beta: multiple effects on cell differentiation and extracellular matrices | Q39471324 | ||
| Fibronectin and its receptors | Q39488078 | ||
| Thrombosis and the development of atherosclerosis: Rokitansky revisited | Q39550303 | ||
| Hydroxyeicosatetraenoic acids (HETEs). | Q39579273 | ||
| Polypeptide growth factors: roles in normal and abnormal cell growth | Q39683843 | ||
| Laminin and other basement membrane components | Q39683846 | ||
| Replication of smooth muscle cells in vascular disease | Q39731571 | ||
| Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action | Q40641303 | ||
| Proteoglycan distribution in catheter-induced aortic lesions in normolipaemic rabbits. An ultrastructural study | Q41242834 | ||
| Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures | Q41541840 | ||
| Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype- and growth state-dependent manner | Q41544649 | ||
| Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation | Q41544843 | ||
| Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells | Q41553699 | ||
| PDGF stimulation of inositol phospholipid hydrolysis requires PLC-gamma 1 phosphorylation on tyrosine residues 783 and 1254. | Q41684625 | ||
| Nuclear localization of endogenous basic fibroblast growth factor in cultured endothelial cells | Q41697148 | ||
| Nuclear and cytoplasmic localization of different basic fibroblast growth factor species | Q41729091 | ||
| Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor | Q41840833 | ||
| Heparin degradation in the endothelial cells | Q41913297 | ||
| Expression of EGF and TGF-alpha genes in early mammalian development | Q42020033 | ||
| Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization | Q42050602 | ||
| Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium antagonist, nilvadipine | Q42143893 | ||
| Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells | Q42497331 | ||
| Electron microscopic study of the prenatal development of the thoracic aorta in the rat. | Q42519088 | ||
| Stimulation of connective tissue cell growth by substance P and substance K. | Q42815612 | ||
| Transformation of NIH 3T3 cells by a human c-sis cDNA clone | Q42819164 | ||
| Collagen synthesis by cultured rabbit aortic smooth-muscle cells. Alteration with phenotype | Q42826785 | ||
| Cell density regulates the number of cell surface receptors for fibroblast growth factor | Q44059743 | ||
| Biological and chemical characterization of basic FGF-saporin mitotoxin | Q44060264 | ||
| Effects of acidic fibroblast growth factor on normal and ischemic myocardium | Q44132656 | ||
| The mitogenic effects of vasoactive neuropeptides on cultured smooth muscle cell lines | Q44153910 | ||
| Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall | Q44193259 | ||
| Correlations between heparan sulfate metabolism and hepatoma growth | Q44201298 | ||
| Expression of acidic and basic fibroblast growth factors in human and bovine vascular smooth muscle cells | Q44471371 | ||
| Bifunctional effects of transforming growth factor-beta on migration of cultured rat aortic smooth muscle cells | Q44499224 | ||
| Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells | Q44595925 | ||
| Immunohistochemical localization of basic and acidic fibroblast growth factors in the developing rat heart | Q44659922 | ||
| Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells | Q44677295 | ||
| Heparin inhibits the inositol 1,4,5-trisphosphate-dependent, but not the independent, calcium release induced by guanine nucleotide in vascular smooth muscle | Q44927616 | ||
| The platelet-derived growth factor isomers, PDGF-AA, PDGF-AB and PDGF-BB, induce contraction of vascular smooth muscle cells by different intracellular mechanisms | Q45054989 | ||
| Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. | Q45191938 | ||
| Heparin-binding growth factor type one and platelet-derived growth factor are required for the optimal expression of cell surface low density lipoprotein receptor binding activity in human adult arterial smooth muscle cells | Q45206703 | ||
| Simian Sarcoma Virus onc Gene, v- sis , Is Derived from the Gene (or Genes) Encoding a Platelet-Derived Growth Factor | Q45798365 | ||
| Vascular smooth muscle relaxation induced by epidermal growth factor is endothelium-dependent | Q45852513 | ||
| Synergistic induction of mesoderm by FGF and TGF-beta and the identification of an mRNA coding for FGF in the early Xenopus embryo. | Q45989344 | ||
| Developmental expression of PDGF, TGF-alpha, and TGF-beta genes in preimplantation mouse embryos | Q46790967 | ||
| Distribution of basic fibroblast growth factor binding sites in various tissue membrane preparations from adult guinea pig. | Q46870944 | ||
| Inhibitory effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size | Q47184209 | ||
| Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis | Q48117290 | ||
| Selective expression of PDGF A and its receptor during early mouse embryogenesis | Q48273847 | ||
| Recent developments in the cell biology of basic fibroblast growth factor | Q24679568 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| A murine fibroblast growth factor (FGF) receptor expressed in CHO cells is activated by basic FGF and Kaposi FGF | Q28115298 | ||
| Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation | Q28296150 | ||
| Culture-induced increase in acidic and basic fibroblast growth factor activities and their association with the nuclei of vascular endothelial and smooth muscle cells | Q28578246 | ||
| Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor | Q29616189 | ||
| Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells | Q30460026 | ||
| Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells | Q30461802 | ||
| Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells | Q30462210 | ||
| Two forms of the basic fibroblast growth factor receptor-like mRNA are expressed in the developing mouse brain | Q33253201 | ||
| cDNA cloning and developmental expression of fibroblast growth factor receptors from Xenopus laevis | Q33337455 | ||
| Evidence for "response to injury" hypothesis | Q33484767 | ||
| Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells | Q33557153 | ||
| Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall | Q33567932 | ||
| Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury | Q33584566 | ||
| Cell proliferation in human coronary arteries | Q33635457 | ||
| Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells | Q33667974 | ||
| Ligand-affinity cloning and structure of a cell surface heparan sulfate proteoglycan that binds basic fibroblast growth factor | Q33784803 | ||
| Ca2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells | Q33847916 | ||
| Regulation of the fibroblast growth factor receptor in early Xenopus embryos | Q33866541 | ||
| Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells | Q33919656 | ||
| Platelet-derived growth factor activity and mRNA expression in healing vascular grafts in baboons. Association in vivo of platelet-derived growth factor mRNA and protein with cellular proliferation | Q34180102 | ||
| Production of transforming growth factor beta 1 during repair of arterial injury | Q34198234 | ||
| Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells | Q34237322 | ||
| Isolation, characterization, and localization of heparin-binding growth factors in the heart | Q34242525 | ||
| Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. | Q34244878 | ||
| Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells | Q34263871 | ||
| Identification of a developmentally regulated protein-tyrosine kinase by using anti-phosphotyrosine antibodies to screen a cDNA expression library | Q34291049 | ||
| Cell biology of arterial proteoglycans. | Q34496708 | ||
| Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization | Q34563319 | ||
| Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats | Q34569768 | ||
| Direct evidence for methylation of arginine residues in high molecular weight forms of basic fibroblast growth factor | Q36742071 | ||
| Specific growth stimulation of cultured smooth muscle cells from spontaneously hypertensive rats by platelet-derived growth factor A-chain homodimer | Q36772499 | ||
| Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix | Q36772532 | ||
| Expression of recombinant platelet-derived growth factor A- and B-chain homodimers in rat-1 cells and human fibroblasts reveals differences in protein processing and autocrine effects | Q36791505 | ||
| Coronary atherosclerosis: current therapeutic approaches and future trends | Q37256203 | ||
| Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury | Q37401242 | ||
| Expressions of the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase genes are stimulated by recombinant platelet-derived growth factor isomers | Q37419979 | ||
| The fibroblast growth factor family | Q37561438 | ||
| Angiotensin II rapidly increases phosphatidate-phosphoinositide synthesis and phosphoinositide hydrolysis and mobilizes intracellular calcium in cultured arterial muscle cells | Q37580327 | ||
| Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors | Q37583409 | ||
| Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner | Q37639452 | ||
| Proteoglycans as modulators of growth factor activities | Q37656847 | ||
| Pathology of atherosclerosis | Q37803957 | ||
| TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights | Q37956083 | ||
| Structure and function of small arteries | Q37969164 | ||
| Cellular interactions, growth factors, and smooth muscle proliferation in atherogenesis | Q38000896 | ||
| Transforming growth factor-alpha | Q38019908 | ||
| Fibroblast growth factor | Q38165946 | ||
| The heparin-binding (fibroblast) growth factor family of proteins | Q38286731 | ||
| Vasoactive effects of growth factors | Q38599993 | ||
| How does extracellular matrix control capillary morphogenesis? | Q38688053 | ||
| Extracellular matrix, cell skeletons, and embryonic development | Q38720415 | ||
| Balloon catheter injury to rabbit carotid artery. I. Changes in smooth muscle phenotype. | Q50888563 | ||
| Recombinant basic fibroblast growth factor accelerates wound healing | Q51770084 | ||
| Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. | Q52244938 | ||
| Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. | Q52245642 | ||
| Regulation of production of a platelet-derived growth factor-like protein by cultured bovine aortic endothelial cells. | Q52686180 | ||
| Expression of PDGF alpha- and beta-receptors in rat arterial smooth muscle cells is phenotype and growth state dependent. | Q53761338 | ||
| Role of basic fibroblast growth factor in vascular lesion formation | Q56428189 | ||
| Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells invitro: Implications for a role of heparinase-like enzymes in the neovascular response | Q56428985 | ||
| Inhibition of endothelial cell proliferation by type β-transforming growth factor: Interactions with acidic and basic fibroblast growth factors | Q56429120 | ||
| INDUCTION OF B-TYPE RECEPTORS FOR PLATELET-DERIVED GROWTH FACTOR IN VASCULAR INFLAMMATION: POSSIBLE IMPLICATIONS FOR DEVELOPMENT OF VASCULAR PROLIFERATIVE LESIONS | Q57352240 | ||
| Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor | Q59052374 | ||
| Developmentally regulated production of platelet-derived growth factor-like molecules | Q59066829 | ||
| Proliferative heterogeneity of vascular smooth muscle cells and its alteration by injury | Q67279401 | ||
| Hormonal requirements for growth of arterial smooth muscle cells in vitro: and endocrine approach to atherosclerosis | Q67295237 | ||
| Detection of the basic fibroblast growth factor low affinity binding site in cardiac sarcolemmal vesicles | Q67300538 | ||
| Electron microscopic observations on the formation of elastic fibers in primary cultures of aortic smooth muscle cells | Q67587855 | ||
| Heparin-binding (fibroblast) growth factors type one and two genes are co-expressed in proliferating normal human vascular endothelial and smooth muscle cells in culture | Q67655253 | ||
| Growth factor activity of endothelin on vascular smooth muscle | Q67655688 | ||
| Suppression of aortic atherosclerosis in cholesterol-fed rabbits by purified rabbit interferon | Q67655711 | ||
| Preferential inhibition of elastin synthesis by epidermal growth factor in chick aortic smooth muscle cells | Q67658043 | ||
| Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells | Q67677615 | ||
| Interleukin-1 beta induces the production of an L-arginine-derived relaxing factor from cultured smooth muscle cells from rat aorta | Q67687724 | ||
| Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner | Q67690118 | ||
| Cytotoxic effects of a recombinant chimeric toxin on rapidly proliferating vascular smooth muscle cells | Q67925869 | ||
| The stimulatory effect of PDGF on vascular smooth muscle cell migration is mediated by the induction of endogenous basic FGF | Q68201411 | ||
| cAMP-mediated regulation of adrenocortical cell bFGF receptors | Q68273451 | ||
| Production of Platelet-Derived Growth Factor–like Mitogen by Smooth-Muscle Cells from Human Atheroma | Q68352602 | ||
| Heparin inhibits Na(+)-H+ exchange in vascular smooth muscle cells | Q68448404 | ||
| TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop | Q68482825 | ||
| Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation | Q68512683 | ||
| Mesoderm induction in amphibians: the role of TGF-beta 2-like factors | Q68519851 | ||
| Regulation of insulin-like growth factor-I gene expression by growth factors in cultured vascular smooth muscle cells | Q68527764 | ||
| Interaction of angiotensin II with functional smooth muscle cells in culture | Q68528784 | ||
| Are calcium ion antagonists effective anti-atherogenic agents? | Q68610425 | ||
| Opposite effects of monokines (interleukin-1 and tumor necrosis factor) on proliferation and heparin-binding (fibroblast) growth factor binding to human aortic endothelial and smooth muscle cells | Q68726675 | ||
| Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries | Q68737335 | ||
| Glycosaminoglycan synthesis by smooth muscle cells of differing phenotype and their response to endothelial cell conditioned medium | Q68808727 | ||
| TGF-beta inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression | Q68818590 | ||
| Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor | Q68820995 | ||
| Transforming growth factor-beta 1 in normal heart and in myocardial infarction | Q68864696 | ||
| Epidermal growth factor | Q68951248 | ||
| Cultured primate aortic smooth muscle cells express both the PDGF-A and PDGF-B genes but do not secrete mitogenic activity or dimeric platelet-derived growth factor protein | Q69041922 | ||
| Cell type and tissue distribution of the fibroblast growth factor receptor | Q69349224 | ||
| Inhibition of myointimal proliferation of the rat carotid artery by the peptides, angiopeptin and BIM 23034 | Q69377602 | ||
| Nifedipine suppressed atherosclerosis in cholesterol-fed rabbits but not in Watanabe heritable hyperlipidemic rabbits | Q69416182 | ||
| Growth factor expression in aorta of normotensive and hypertensive rats | Q34571323 | ||
| Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells | Q34571434 | ||
| Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor | Q34617842 | ||
| Evidence for a functional role of endogenously produced somatomedinlike peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells | Q34630317 | ||
| Novel tyrosine kinase identified by phosphotyrosine antibody screening of cDNA libraries | Q35136895 | ||
| Stimulation of aortic smooth muscle cell mitogenesis by serotonin | Q35588425 | ||
| Heterogeneity of smooth muscle cells in atheromatous plaque of human aorta | Q35811302 | ||
| Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells | Q35811693 | ||
| Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells | Q35811776 | ||
| Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens | Q36204340 | ||
| Factors controlling the proliferative rate, final cell density, and life span of bovine vascular smooth muscle cells in culture | Q36204930 | ||
| Heparin regulates the collagen phenotype of vascular smooth muscle cells: induced synthesis of an Mr 60,000 collagen | Q36211592 | ||
| A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes | Q36211832 | ||
| Accelerated wound repair, cell proliferation, and collagen accumulation are produced by a cartilage-derived growth factor | Q36212902 | ||
| Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells | Q36214722 | ||
| Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix | Q36218428 | ||
| Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex | Q36220322 | ||
| Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture | Q36220333 | ||
| Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms | Q36220355 | ||
| Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells | Q36221997 | ||
| Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity | Q36222670 | ||
| Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta | Q36223233 | ||
| Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro | Q36223450 | ||
| PDGF ligand and receptor gene expression during repair of arterial injury | Q36223935 | ||
| Aging and arteriosclerosis. The increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity | Q36354361 | ||
| Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock | Q36356245 | ||
| Platelet-derived growth factor and autocrine mechanisms of oncogenic processes | Q36404297 | ||
| Cytokines in context | Q36529819 | ||
| Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration | Q36529887 | ||
| Acidic fibroblast growth factor in the developing rat embryo | Q36530293 | ||
| Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation | Q36618743 | ||
| Function follows form: generation of intracellular signals by cell deformation | Q36636941 | ||
| Extracellular matrix-resident basic fibroblast growth factor: Implication for the control of angiogenesis | Q36657969 | ||
| Heparin and hormonal regulation of mRNA synthesis and abundance of autocrine growth factors: relevance to clonal growth of tumors | Q36679758 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell growth | Q189159 |
| P304 | page(s) | 177-206 | |
| P577 | publication date | 1991-01-01 | |
| P1433 | published in | Progress in growth factor research | Q27709386 |
| P1476 | title | Smooth muscle cell growth factors | |
| P478 | volume | 3 |
| Q35834095 | CD4+ mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury. |
| Q53394773 | Clitocybin B inhibits rat aortic smooth muscle cell proliferation through suppressing PDGF-Rβ phosphorylation. |
| Q41185529 | Eicosanoids, fatty acids and restenosis following coronary artery bypass graft surgery and balloon angioplasty |
| Q37138232 | Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors |
| Q73579084 | High and constant plasma levels of tissue plasminogen activator and PEG-hirudin can be achieved by subcutaneous delivery |
| Q31804184 | Inhibitory effect of pentalenolactone on vascular smooth muscle cell proliferation |
| Q37127450 | Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. |
| Q40486896 | Mechanisms of restenosis |
| Q35915178 | Molecular atherectomy for restenosis |
| Q33862443 | Platelets and restenosis |
| Q61955174 | Regulation of plasminogen activator inhibitor type 1 in cultured smooth muscle cells by interleukin 1α and tumour necrosis factor-α |
| Q30445019 | Serum stimulation, cell-cell interactions, and extracellular matrix independently influence smooth muscle cell phenotype in vitro. |
| Q35925223 | Smooth muscle cell signal transduction: implications of vascular biology for vascular surgeons. |
| Q45958204 | Stimulation of endothelial cells by doses of basic FGF-saporin that are lethal to smooth muscle cells. |
| Q41489951 | Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity |
Search more.